The Effect of Nutritional Interventions on Exercise-induced Muscle Damage
NCT ID: NCT02839525
Last Updated: 2017-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2016-07-26
2017-02-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The procedures will be performed at the Federal University of Health of Porto Alegre (UFCSPA).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women
NCT03247192
Effects of Omega-3 and Whey Protein Supplementation on Lean Mass in Older Adults
NCT05862779
Whey Protein Supplementation and Resistance Training in Older Women With Sarcopenic Obesity.
NCT03752359
Acute Study on Muscle Soreness, Damage, and Performance
NCT04230226
Vegan Whey Protein for Muscle Anabolism and Post-exercise Recovery
NCT07119749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The order of procedures to be performed will be: (1) Nutritional and Anthropometric assessment; (2) Individual orientation of diet and distribution of supplements; (3) Baseline assessment (peak torque, muscle pain levels and vastus lateralis and rectus femoris echo intensity; (4) Muscle damage induction by eccentric exercise protocol; (5) Reviews after 24h, 48h, 72h, which will follow the routine and the methods applied at baseline.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Omega 3
* 3000mg of olive oil
* Eccentric exercise: 100 maximal eccentric contractions of knee extensors, divided into 10 sets of 10 repetitions at intervals of 60 seconds between the series
Omega 3
3000mg of n-3 oil (2000mg EPA e 1000mg DHA)
Eccentric exercise
100 maximal eccentric contractions of knee extensors, divided into 10 sets of 10 repetitions at intervals of 60 seconds between the series
Isolate whey protein
* 23g of maltodextrin
* Eccentric exercise: 100 maximal eccentric contractions of knee extensors, divided into 10 sets of 10 repetitions at intervals of 60 seconds between the series
Isolate whey protein
23g of protein of whey protein
Eccentric exercise
100 maximal eccentric contractions of knee extensors, divided into 10 sets of 10 repetitions at intervals of 60 seconds between the series
Omega 3 and Isolate whey protein
* 3000mg of olive oil and 23g of maltodextrin
* Eccentric exercise: 100 maximal eccentric contractions of knee extensors, divided into 10 sets of 10 repetitions at intervals of 60 seconds between the series
Omega 3 and Isolate whey protein
3000mg of n-3 oil (2000mg EPA e 1000mg DHA) and 23g of protein of whey protein
Eccentric exercise
100 maximal eccentric contractions of knee extensors, divided into 10 sets of 10 repetitions at intervals of 60 seconds between the series
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Omega 3
3000mg of n-3 oil (2000mg EPA e 1000mg DHA)
Isolate whey protein
23g of protein of whey protein
Omega 3 and Isolate whey protein
3000mg of n-3 oil (2000mg EPA e 1000mg DHA) and 23g of protein of whey protein
Eccentric exercise
100 maximal eccentric contractions of knee extensors, divided into 10 sets of 10 repetitions at intervals of 60 seconds between the series
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 18,5-25kg/m2
* physical exercise: \< 150 minutes per week
Exclusion Criteria
* vegetarian/vegan
* chronic disease
* pulmonary and neurologic disease
* muscle injury/knee muscle injury
* medication use: anti-inflammatory and anticoagulant
* fish oil and derivate allergy
* dietary supplements use in the last month: whey protein, casein, albumin, glutamin, meat and soy protein, creatine, branched chain amino acid, high calorie supplement, n-3 supplement and antioxidants
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of Health Science of Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
LetÃcia Chisini Loss
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claudia Dornelles Schneider, Doctor
Role: PRINCIPAL_INVESTIGATOR
Federal University of Health Science of Porto Alegre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UFCSPA
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
51384015.5.0000.5345
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.